Government Needs to Encourage – Not Suppress – Drug Competition

By Dan Leonard

Six new copycat versions of Humira – one of the top-selling prescription drugs in the United States – just hit the market. Cyltezo is the first interchangeable Biosimilar for Humira, and another named Yusimry, is about 85% cheaper than the brand-name product. In total there will be eight available Biosimilar competitors to Humira available in the coming weeks...